Emcure Pharma up over 3% as board approves merger of two subsidiaries

Emcure Pharmaceuticals will merge its wholly owned subsidiaries, Zuventus Healthcare and Emcutix Biopharmaceuticals, with itself under the proposed scheme.

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.business-standard.com)